Avoro Capital Advisors LLC Verrica Pharmaceuticals Inc. Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,999,999 shares of VRCA stock, worth $32.5 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
3,999,999
Previous 3,999,999
-0.0%
Holding current value
$32.5 Million
Previous $29.3 Million
19.13%
% of portfolio
0.29%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding VRCA
# of Institutions
61Shares Held
16.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY7.1MShares$57.6 Million0.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.27MShares$10.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.11MShares$9.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.65 Million0.0% of portfolio
-
State Street Corp Boston, MA413KShares$3.35 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $334M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...